A study investigating the effects of sitagliptin on heart muscle performance in patients with heart disease and diabetes

Completed

• Conditions: Coronary artery disease; Circulatory System; Chronic ischaemic heart disease

• Registration Number: ISRCTN78649100
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07-11
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Subjects aged 35 - 80 years with coronary disease awaiting revascularisation with normal left ventricular (LV) function with insulin resistance.

Exclusion Criteria

1. Atrial fibrillation
2. Pacemakers
3. Valvular heart disease
4. Renal failure

Study & Design

• Study Type: Interventional
• Study Design: Not specified